Mineralocorticoid axis activity and cardiac remodeling in patients with ACTH-dependent Cushing’s syndrome

Background: Arterial hypertension and left ventricular hypertrophy and remodeling are independent cardiovascular risk factors in patients with Cushing’s syndrome. Changes in the renin–angiotensin system and in the mineralocorticoid axis activity could be involved as potential mechanisms in their pat...

Full description

Saved in:
Bibliographic Details
Main Authors: Peter Wolf, Simon Travers, Oliver Domenig, Stephanie Baron, Anne Blanchard, Khaoula Bouazizi, Nadjia Kachenoura, Sylvie Salenave, Marko Poglitsch, Alban Redheuil, Severine Trabado, Jacques Young, Philippe Chanson, Peter Kamenický
Format: Article
Language:English
Published: Bioscientifica 2025-01-01
Series:Endocrine Connections
Subjects:
Online Access:https://ec.bioscientifica.com/view/journals/ec/14/2/EC-24-0617.xml
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832098681292062720
author Peter Wolf
Simon Travers
Oliver Domenig
Stephanie Baron
Anne Blanchard
Khaoula Bouazizi
Nadjia Kachenoura
Sylvie Salenave
Marko Poglitsch
Alban Redheuil
Severine Trabado
Jacques Young
Philippe Chanson
Peter Kamenický
author_facet Peter Wolf
Simon Travers
Oliver Domenig
Stephanie Baron
Anne Blanchard
Khaoula Bouazizi
Nadjia Kachenoura
Sylvie Salenave
Marko Poglitsch
Alban Redheuil
Severine Trabado
Jacques Young
Philippe Chanson
Peter Kamenický
author_sort Peter Wolf
collection DOAJ
description Background: Arterial hypertension and left ventricular hypertrophy and remodeling are independent cardiovascular risk factors in patients with Cushing’s syndrome. Changes in the renin–angiotensin system and in the mineralocorticoid axis activity could be involved as potential mechanisms in their pathogenesis, in addition to cortisol excess. Methods: In this ancillary study of our previous study prospectively investigating patients with ACTH-dependent Cushing’s syndrome by cardiac magnetic resonance imaging (NCT02202902), 11 patients without any interfering medication were cross-sectionally compared to 20 control subjects matched for age, sex and body mass index. Angiotensin metabolites and adrenal steroids were measured by liquid chromatography tandem mass spectrometry, and their relation to blood pressure and cardiac structure was evaluated. Results: Concentrations of angiotensin I and angiotensin II were comparable, but the angiotensin-converting enzyme activity was significantly lower (2.19 (1.67; 3.08) vs 4.07 (3.1; 5.6); P < 0.001) in patients compared to controls. Aldosterone concentrations were significantly lower (6.9 (6.9; 124.1) vs 239.9 (181.4; 321.9) pmol/L; P < 0.001) in the group of patients, but adrenal aldosterone precursor metabolites were comparable between patients and controls. Inverse correlations were observed for 24 h urinary free cortisol and aldosterone with the ratio of left ventricular mass to end-diastolic volume (r = 0.470, P = 0.012 and r = −0.367, P = 0.046, respectively). Conclusions: We describe a disease-specific profile of angiotensin metabolites in patients with ACTH-dependent Cushing’s syndrome. Low levels of aldosterone in the presence of unchanged precursor metabolites indicate a direct inhibitory action of cortisol excess on the aldosterone synthase. Furthermore, glucocorticoid excess per se drives cardiac muscle remodeling.
format Article
id doaj-art-256175dfc34b4e2a9bc6b2f7b0f5750d
institution Kabale University
issn 2049-3614
language English
publishDate 2025-01-01
publisher Bioscientifica
record_format Article
series Endocrine Connections
spelling doaj-art-256175dfc34b4e2a9bc6b2f7b0f5750d2025-02-05T10:14:00ZengBioscientificaEndocrine Connections2049-36142025-01-0114210.1530/EC-24-06171Mineralocorticoid axis activity and cardiac remodeling in patients with ACTH-dependent Cushing’s syndromePeter Wolf0Simon Travers1Oliver Domenig2Stephanie Baron3Anne Blanchard4Khaoula Bouazizi5Nadjia Kachenoura6Sylvie Salenave7Marko Poglitsch8Alban Redheuil9Severine Trabado10Jacques Young11Philippe Chanson12Peter Kamenický13Université Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, FranceUniversité Paris Cité, PARCC, Inserm, Paris, FranceAttoquant Diagnostics, Vienna, AustriaUniversité Paris Cité, PARCC, Inserm, Paris, FranceUniversité Paris Cité, PARCC, Inserm, Paris, FranceSorbonne Université, CNRS, Inserm, Laboratoire d’Imagerie Biomédicale, LIB, Paris, FranceSorbonne Université, CNRS, Inserm, Laboratoire d’Imagerie Biomédicale, LIB, Paris, FranceUniversité Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, FranceAttoquant Diagnostics, Vienna, AustriaInstitut de Cardiométabolisme et Nutrition (ICAN), Paris, FranceAssistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service de Génétique Moléculaire, Pharmacogénétique et Hormonologie, Le Kremlin-Bicêtre, FranceUniversité Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, FranceUniversité Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, FranceUniversité Paris-Saclay, Inserm, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares de l’Hypophyse, Le Kremlin-Bicêtre, FranceBackground: Arterial hypertension and left ventricular hypertrophy and remodeling are independent cardiovascular risk factors in patients with Cushing’s syndrome. Changes in the renin–angiotensin system and in the mineralocorticoid axis activity could be involved as potential mechanisms in their pathogenesis, in addition to cortisol excess. Methods: In this ancillary study of our previous study prospectively investigating patients with ACTH-dependent Cushing’s syndrome by cardiac magnetic resonance imaging (NCT02202902), 11 patients without any interfering medication were cross-sectionally compared to 20 control subjects matched for age, sex and body mass index. Angiotensin metabolites and adrenal steroids were measured by liquid chromatography tandem mass spectrometry, and their relation to blood pressure and cardiac structure was evaluated. Results: Concentrations of angiotensin I and angiotensin II were comparable, but the angiotensin-converting enzyme activity was significantly lower (2.19 (1.67; 3.08) vs 4.07 (3.1; 5.6); P < 0.001) in patients compared to controls. Aldosterone concentrations were significantly lower (6.9 (6.9; 124.1) vs 239.9 (181.4; 321.9) pmol/L; P < 0.001) in the group of patients, but adrenal aldosterone precursor metabolites were comparable between patients and controls. Inverse correlations were observed for 24 h urinary free cortisol and aldosterone with the ratio of left ventricular mass to end-diastolic volume (r = 0.470, P = 0.012 and r = −0.367, P = 0.046, respectively). Conclusions: We describe a disease-specific profile of angiotensin metabolites in patients with ACTH-dependent Cushing’s syndrome. Low levels of aldosterone in the presence of unchanged precursor metabolites indicate a direct inhibitory action of cortisol excess on the aldosterone synthase. Furthermore, glucocorticoid excess per se drives cardiac muscle remodeling.https://ec.bioscientifica.com/view/journals/ec/14/2/EC-24-0617.xmlcushing’s syndromehypertensionangiotensinaldosteroneras system
spellingShingle Peter Wolf
Simon Travers
Oliver Domenig
Stephanie Baron
Anne Blanchard
Khaoula Bouazizi
Nadjia Kachenoura
Sylvie Salenave
Marko Poglitsch
Alban Redheuil
Severine Trabado
Jacques Young
Philippe Chanson
Peter Kamenický
Mineralocorticoid axis activity and cardiac remodeling in patients with ACTH-dependent Cushing’s syndrome
Endocrine Connections
cushing’s syndrome
hypertension
angiotensin
aldosterone
ras system
title Mineralocorticoid axis activity and cardiac remodeling in patients with ACTH-dependent Cushing’s syndrome
title_full Mineralocorticoid axis activity and cardiac remodeling in patients with ACTH-dependent Cushing’s syndrome
title_fullStr Mineralocorticoid axis activity and cardiac remodeling in patients with ACTH-dependent Cushing’s syndrome
title_full_unstemmed Mineralocorticoid axis activity and cardiac remodeling in patients with ACTH-dependent Cushing’s syndrome
title_short Mineralocorticoid axis activity and cardiac remodeling in patients with ACTH-dependent Cushing’s syndrome
title_sort mineralocorticoid axis activity and cardiac remodeling in patients with acth dependent cushing s syndrome
topic cushing’s syndrome
hypertension
angiotensin
aldosterone
ras system
url https://ec.bioscientifica.com/view/journals/ec/14/2/EC-24-0617.xml
work_keys_str_mv AT peterwolf mineralocorticoidaxisactivityandcardiacremodelinginpatientswithacthdependentcushingssyndrome
AT simontravers mineralocorticoidaxisactivityandcardiacremodelinginpatientswithacthdependentcushingssyndrome
AT oliverdomenig mineralocorticoidaxisactivityandcardiacremodelinginpatientswithacthdependentcushingssyndrome
AT stephaniebaron mineralocorticoidaxisactivityandcardiacremodelinginpatientswithacthdependentcushingssyndrome
AT anneblanchard mineralocorticoidaxisactivityandcardiacremodelinginpatientswithacthdependentcushingssyndrome
AT khaoulabouazizi mineralocorticoidaxisactivityandcardiacremodelinginpatientswithacthdependentcushingssyndrome
AT nadjiakachenoura mineralocorticoidaxisactivityandcardiacremodelinginpatientswithacthdependentcushingssyndrome
AT sylviesalenave mineralocorticoidaxisactivityandcardiacremodelinginpatientswithacthdependentcushingssyndrome
AT markopoglitsch mineralocorticoidaxisactivityandcardiacremodelinginpatientswithacthdependentcushingssyndrome
AT albanredheuil mineralocorticoidaxisactivityandcardiacremodelinginpatientswithacthdependentcushingssyndrome
AT severinetrabado mineralocorticoidaxisactivityandcardiacremodelinginpatientswithacthdependentcushingssyndrome
AT jacquesyoung mineralocorticoidaxisactivityandcardiacremodelinginpatientswithacthdependentcushingssyndrome
AT philippechanson mineralocorticoidaxisactivityandcardiacremodelinginpatientswithacthdependentcushingssyndrome
AT peterkamenicky mineralocorticoidaxisactivityandcardiacremodelinginpatientswithacthdependentcushingssyndrome